LinkedIn facebook twitter youtube



As part of the CARAMBA consortium, Myeloma Patients Europe (MPE) has developed an information sheet to explain the main goals and characteristics of the CARAMBA clinical trial investigating SLAMF7 chimeric antigen receptor T-cell (CAR-T) therapy. This publication discusses some potential CAR-T side effects and considerations for patients and caregivers. This information sheet has been previously published on our website in English and is now available in four additional languages: French, Italian, Spanish and German. Continue reading


Location: Scotland / home based (approx. 10 travel days per year)

Contract: 40 hours per week / permanent

Salary: £25,000 – £27,000 depending on experience


This Research Assistant post supports the research function of Myeloma Patients Europe (MPE). There are two main elements to the job – supporting communication and dissemination of SISAQOL-IMI and to assist with generating patient centred evidence as part of MPE’s newly established Evidence Generation Unit (EGU). The following tasks and core responsibilities are non-exhaustive and subject to change depending on needs of the organisation.

Continue reading